IBDEI2GG ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,41638,1,4,0)
 ;;=4^R50.9
 ;;^UTILITY(U,$J,358.3,41638,2)
 ;;=^5019512
 ;;^UTILITY(U,$J,358.3,41639,0)
 ;;=R76.11^^159^2006^1
 ;;^UTILITY(U,$J,358.3,41639,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41639,1,3,0)
 ;;=3^Abnormal Reaction to TB Test w/o Active TB
 ;;^UTILITY(U,$J,358.3,41639,1,4,0)
 ;;=4^R76.11
 ;;^UTILITY(U,$J,358.3,41639,2)
 ;;=^5019570
 ;;^UTILITY(U,$J,358.3,41640,0)
 ;;=Z21.^^159^2006^30
 ;;^UTILITY(U,$J,358.3,41640,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41640,1,3,0)
 ;;=3^HIV Asymptomatic,Infection Status
 ;;^UTILITY(U,$J,358.3,41640,1,4,0)
 ;;=4^Z21.
 ;;^UTILITY(U,$J,358.3,41640,2)
 ;;=^5062777
 ;;^UTILITY(U,$J,358.3,41641,0)
 ;;=B37.0^^159^2006^16
 ;;^UTILITY(U,$J,358.3,41641,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41641,1,3,0)
 ;;=3^Candidal Stomatitis (Oral Thrush)
 ;;^UTILITY(U,$J,358.3,41641,1,4,0)
 ;;=4^B37.0
 ;;^UTILITY(U,$J,358.3,41641,2)
 ;;=^5000612
 ;;^UTILITY(U,$J,358.3,41642,0)
 ;;=B97.10^^159^2006^22
 ;;^UTILITY(U,$J,358.3,41642,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41642,1,3,0)
 ;;=3^Enterovirus,Unspec,as Cause of Disease
 ;;^UTILITY(U,$J,358.3,41642,1,4,0)
 ;;=4^B97.10
 ;;^UTILITY(U,$J,358.3,41642,2)
 ;;=^5000861
 ;;^UTILITY(U,$J,358.3,41643,0)
 ;;=R50.82^^159^2006^24
 ;;^UTILITY(U,$J,358.3,41643,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41643,1,3,0)
 ;;=3^Fever,Postprocedural
 ;;^UTILITY(U,$J,358.3,41643,1,4,0)
 ;;=4^R50.82
 ;;^UTILITY(U,$J,358.3,41643,2)
 ;;=^5019509
 ;;^UTILITY(U,$J,358.3,41644,0)
 ;;=R50.83^^159^2006^26
 ;;^UTILITY(U,$J,358.3,41644,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41644,1,3,0)
 ;;=3^Fever,Postvaccination
 ;;^UTILITY(U,$J,358.3,41644,1,4,0)
 ;;=4^R50.83
 ;;^UTILITY(U,$J,358.3,41644,2)
 ;;=^5019510
 ;;^UTILITY(U,$J,358.3,41645,0)
 ;;=R50.84^^159^2006^25
 ;;^UTILITY(U,$J,358.3,41645,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41645,1,3,0)
 ;;=3^Fever,Posttransfusion
 ;;^UTILITY(U,$J,358.3,41645,1,4,0)
 ;;=4^R50.84
 ;;^UTILITY(U,$J,358.3,41645,2)
 ;;=^5019511
 ;;^UTILITY(U,$J,358.3,41646,0)
 ;;=B02.23^^159^2006^70
 ;;^UTILITY(U,$J,358.3,41646,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41646,1,3,0)
 ;;=3^Postherpetic Polyneuropathy
 ;;^UTILITY(U,$J,358.3,41646,1,4,0)
 ;;=4^B02.23
 ;;^UTILITY(U,$J,358.3,41646,2)
 ;;=^266550
 ;;^UTILITY(U,$J,358.3,41647,0)
 ;;=B02.22^^159^2006^71
 ;;^UTILITY(U,$J,358.3,41647,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41647,1,3,0)
 ;;=3^Postherpetic Trigeminal Neuralgia
 ;;^UTILITY(U,$J,358.3,41647,1,4,0)
 ;;=4^B02.22
 ;;^UTILITY(U,$J,358.3,41647,2)
 ;;=^266546
 ;;^UTILITY(U,$J,358.3,41648,0)
 ;;=J03.91^^159^2006^80
 ;;^UTILITY(U,$J,358.3,41648,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41648,1,3,0)
 ;;=3^Tonsillitis,Acute Recurrent,Unspec
 ;;^UTILITY(U,$J,358.3,41648,1,4,0)
 ;;=4^J03.91
 ;;^UTILITY(U,$J,358.3,41648,2)
 ;;=^5008136
 ;;^UTILITY(U,$J,358.3,41649,0)
 ;;=K70.0^^159^2007^3
 ;;^UTILITY(U,$J,358.3,41649,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41649,1,3,0)
 ;;=3^Alcoholic Fatty Liver
 ;;^UTILITY(U,$J,358.3,41649,1,4,0)
 ;;=4^K70.0
 ;;^UTILITY(U,$J,358.3,41649,2)
 ;;=^5008784
 ;;^UTILITY(U,$J,358.3,41650,0)
 ;;=K70.11^^159^2007^7
 ;;^UTILITY(U,$J,358.3,41650,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41650,1,3,0)
 ;;=3^Alcoholic Hepatitis w/ Ascites
 ;;^UTILITY(U,$J,358.3,41650,1,4,0)
 ;;=4^K70.11
 ;;^UTILITY(U,$J,358.3,41650,2)
 ;;=^5008786
 ;;^UTILITY(U,$J,358.3,41651,0)
 ;;=K70.10^^159^2007^8
 ;;^UTILITY(U,$J,358.3,41651,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41651,1,3,0)
 ;;=3^Alcoholic Hepatitis w/o Ascites
 ;;^UTILITY(U,$J,358.3,41651,1,4,0)
 ;;=4^K70.10
